Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Clinical trial NCT06445517 · RECRUITING
Trial details
- NCT number
- NCT06445517
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-25
- Primary completion
- 2026-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.